Effect of vitamin C supplementation on oxidative stress and lipid profiles in hemodialysis patients

International Journal for Vitamin and Nutrition Research

Volumn 79, Issue 5-6, 2009, Pages 281-287

  Abdollahzad, Hadi ^a,b   Eghtesadi, Shahriar ^b   Nourmohammadi, Issa ^c   Khadem Ansari, Mohammadhasan ^d   Nejad Gashti, Hossein ^e   Esmaillzadeh, Ahmad ^f  

^a ZABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular disease; Hemodialysis; Lipids; Malondialdehyde; Oxidative stress; Vitamin C

Indexed keywords

ASCORBIC ACID; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PLACEBO; TRIACYLGLYCEROL; ANTIOXIDANT; CHOLESTEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LIPID BLOOD LEVEL; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION; AGED; BLOOD; DIET SUPPLEMENTATION; DRUG EFFECT; LIPID METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; RENAL REPLACEMENT THERAPY;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; CHOLESTEROL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LIPID METABOLISM; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; RENAL DIALYSIS; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES; YOUNG ADULT;

EID: 77954741252     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.79.5.281     Document Type: Article

References (33)

1. th ed., pp. 970-2, W.B. Saunders, Philadelphia, PA.
2. Schulman, J. and Himmelfarb, J. (2004) Hemodialysis. In: Brener & Rector's The Kidney. (Brener, B.M., ed.) 7th ed., pp. 2563-64, W.B. Saunders, Philadelphia. PA.
3. Islam, K.N., O'Byrne, D., Devaraj, S., Palmer, B., Grundy, S.M. and Jialal I. )2000) Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis 150, 217-224.
4. Boaz, M., Smetana, S., Weinstein, T., Matas, Z., Gafter, U., Iaina, A., Kencht, A., Weissgarten, Y., Brunner , D., Fainaru, M. and Green, M.S. (2000) Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): randomized placebo-controlled trial. Lancet 356,1213-18.
5. Jung, H.H., Choi, D.H. and Lee, S.H. (2004) Serum malondialdehyde and coronary artery disease in hemodialysis patients. Am. J. Nephrol. 24,537-542.
6. Nakamura, S., Sasaki, O., Nakahama, H., Inenaga, T. and Kawano, Y. (2002) Clinical characteristics and survival in end-stage renal disease patients with arteriosclerosis obliterans. Am. J. Nephrol. 22, 422-428.
7. Bonanome, A., Biasia, F., Luca, M.D., Munaretto, G., Biffanti, S., Pradella, M. and Pagnan, A. (1996) N-3 fatty acids do not enhance LDL susceptibility to oxidation in hypertriacylglyceridemic hemodialyzed subjects. Am. J. Clin. Nutr. 63,261.
8. Clermont, G., Lecour, S., Lahet, J.J., Siohan, P., Vergely, C., Chevet, D., Rifle, G. and Rochette, L. (2000) Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc. Res. 47,618-623.
9. Handelman, G.J. (2000) Evaluation of oxidant stress in dialysis patients. Blood Purif. 18,343-349.
10. Boaz, M., Matas, Z., Biro, A., Katzir, Z., Green, M., Fainaru, M. and Smetana, S. (1999) Serum malondialdhyde and prevalent cardiovascular disease in hemodialysis. Kidney Int. 56,1078-1083. (Pubitemid 29411736)
11. Nielsen, F., Mikkelsen, B.B., Nielsen, J.B., Andersen, H.R. and Grandjean, P. (1997) Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin. Chem. 43,1209-1214.
12. Wratten, M.L., Tetta, C., Ursini, F. and Sevanian, A. (2000) Oxidant stress in hemodialysis: prevention and treatment strategies. Kidney Int. 58,S126-S132.
13. Frei, B., England, L. and Ames, B.N. (1989) Ascorbate is an outstanding antioxidant in human blood plasma. Proc. Natl. Acad. Sci. USA 86,6377-6381.
14. Deicher, R. and Horl, W.H. (2003) Vitamin C in chronic kidney disease and hemodialysis patients. Kidney Blood Press. Res. 26,100-106.
15. th ed., pp. 1458-1459. Lippincott Williams & Wilkins, Philadelphia, PA.
16. Lowry, O.H., Lopez, J.A. and Bessey, O.A. (1945) The determination of ascorbic acid in small amounts of blood serum. J. Biol. Chem. 160, 609-615.
17. Satoh, K. (1978) Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica Chemica Acta 90,37-43.
18. Rifai, N., Backorik, P.S. and Albers, J.J. (1999) Lipids, Lipoproteins and Apolipoproteins. In: Tietz Textbook of Clinical Chemistry. (Burtis, C.A. and Ashwood, E.R., eds.), 3rd ed., pp. 809-861, W.B. Saunders Company, Philadelphia.
19. Chao, J.C.J., Yuan, M.D., Chen, P.Y. and Chien, S.W. (2002) Vitamin C and E supplements improve the impaired antioxidant status and decrease plasma lipid peroxides in hemodialysis patients. J. Nutr. Biochem. 13, 653-663.
20. Ono, K. (1989) The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients. Clin. Nephrol. 31, 31-34.
21. Candan, F. and Gultekin, F. (2002) Effect of vitamin C and zinc on osmotic fragility and lipid peroxidation in zinc-deficient haemodialysis patients. Cell Biochem. Funct. 20, 95-98.
22. Wen, Y. and Feely, J. (1997) The effect of pharmacological supplementation with vitamin C on LDL oxidation. Br. J. Clin. Pharmacol. 44, 94-97.
23. Nakazawa, R., Motohashi, K., Azuma, N., Suzuki, M. and Ogawa, Y. (2002) Impact of low dose vitamin C supplementation on oxidative stress and serum oxalate in haemodialysis patients. Nephrology Dialysis Transplantation 17(supp 1), 279.
24. Levine, M., Rumsey, S.C., Daruwala, R., Park, J.B. and Wang, Y. (1999) Criteria and recommendations for vitamin C intake. JAMA 281, 1415-1423.
25. Phil, S.D. and Srivastava, L.M. (1997) Effect of ascorbic acid on lipid profile and lipid peroxidation in hypercholesterolemic rabbits. Nutr. Res. 17, 231-241.
26. Anderson, D., Phillips, B.J., Yu, T.W., Edwards, A.J. and Ayesh, R. (1997) The effects of vitamin C supplementation on biomarkers of oxygen radical generated damage in human volunteers with low or high cholesterol level. Environ. Mol. Mutagen. 30, 161-174.
27. Khajehdehi, P. (2000) Effect of vitamins on the lipid profile of patients on regular hemodialysis. Scand. J. Urol. Nephrol34, 62-66.
28. Ginter, E. (1977) Effect of ascorbic acid on plasma cholesterol in humans in a long-term experiment. Int. J. Vitam. Nutr. Res. 47, 123-134.
29. Morena, M., Cristol, J.P., Bosc, J.Y. et al. (1998) Convective and diffusive losses of vitamin C during hemodiafiltration session: a contributive factor to oxidative stress in HD patients. Nephrol. Dial. Transplant. 13,A200.
30. Ward, R.A. and McLeish, K.R. (1995) HD with cellulose membranes primes the neutrophil oxidative burst. Artif. Organs 19,801-7.
31. Cristol, J.P., Canaud, B., Rabesandratana, H., Gaillard, I., Serre, A. and Mion, C. (1994) Enhancement of reactive oxygen species production and cell surface markers expression due to haemodialysis. Nephrol. Dial. Transplant. 9,389-94.
32. Wratten, M.L., Sereni, L., Tropea, F. and Tetta, C. (1998) Hemolipodialysis removes hydrophobic toxins and reduces oxidative stress in an in vitro model system. Nephrol. Dial. Transplant. 13,A184.
33. Önvural, B., Öztüre, H., Önvural, A. and Fadiloglu, M. (1998) Lipid metabolism in postmenopausal women. Turkish J. of Med. Sci. 28,519-524.